Table 3. Subgroup analysis in patients with heart failure with reduced ejection fraction and SBP < 100 mmHg.
| SBP < 90 mmHg (n = 19) | 90 mmHg ≤ SBP < 100 mmHg (n = 28) | P-value | ||||
| Difference (95% CI) | P-value | Difference (95% CI) | P-value | |||
| SBP: systolic blood pressure. | ||||||
| Left ventricular ejection fraction, % | 9.7 (3.7–15.7) | 0.004 | 11.6 (7.9–15.3) | < 0.001 | 0.54 | |
| Left ventricular end-diastolic diameter, mm | -1.6 (-5.0–1.9) | 0.346 | -4.6 (-7.7–-1.6) | 0.004 | 0.17 | |
| Left atrium diameter, mm | -1.5 (-4.2–1.1) | 0.232 | -4.2 (-7.7–-0.7) | 0.020 | 0.24 | |
| N-terminal pro-B-type natriuretic peptide, pg/mL | -1509.9 (-2332.5–-687.3) | 0.002 | -787.0 (-4083.6–-431.8) | 0.002 | 0.72 | |
| SBP, mmHg | 6.9 (0.1–13.7) | 0.048 | 8.0 (2.4–13.5) | 0.007 | 0.80 | |
| Heart rate, beats/min | -10 (-0.5–25.0) | 0.073 | -12 (2.0–20.5) | 0.023 | 0.88 | |
| Estimated glomerular filtration rate, mL/min per 1.73 m2 |
5.5 (-9.2–20.2) | 0.423 | 9.1 (-0.8–18.9) | 0.067 | 0.65 | |
| Serium potassium, mmol/L | 0.2 (-0.1–0.4) | 0.150 | 0.1 (-0.1–0.3) | 0.377 | 0.72 | |